Abstract: An activated carbon powder comprising activated carbon particles that comprise D-band carbon corresponding to a sp3 hybridized disordered carbon phase and G-band carbon corresponding to a sp2 hybridized graphitic phase at a controlled proportion. Additionally, the activated carbon particles comprise nitrogen at an amount that is in a range of about 0.3 atomic % to about 1.8 atomic % of the activated carbon particles, wherein at least some of the nitrogen atoms are substituted for carbon atoms in the crystal lattice structure of the G-band carbon. Also, the carbon particles have a surface area that is in a range of about 900 m2/g to about 2,500 m2/g, an average pore width in a range of about 1 nm to about 4 nm, a microporous surface area in a range of about 300 m2/g to about 1,350 m2/g, and a cumulative surface area of pores with a hydraulic radius in a range of 0.285 nm to 1.30 nm that is in a range of about 1,000 m2/g to about 3,000 m2/g.

Abstract: An activated carbon powder comprising activated carbon particles that comprise D-band carbon corresponding to a sp3 hybridized disordered carbon phase and G-band carbon corresponding to a sp2 hybridized graphitic phase at a controlled proportion. Additionally, the activated carbon particles comprise nitrogen at an amount that is in a range of about 0.3 atomic % to about 1.8 atomic % of the activated carbon particles, wherein at least some of the nitrogen atoms are substituted for carbon atoms in the crystal lattice structure of the G-band carbon. Also, the carbon particles have a surface area that is in a range of about 900 m2/g to about 2,500 m2/g, an average pore width in a range of about 1 nm to about 4 nm, a microporous surface area in a range of about 300 m2/g to about 1,350 m2/g, and a cumulative surface area of pores with a hydraulic radius in a range of 0.285 nm to 1.30 nm that is in a range of about 1,000 m2/g to about 3,000 m2/g.

Abstract: A stabilizer composition for producing a polymeric hollow article in a rotomolding process has stabilizing amounts of: (i) at least one chroman-based compound according to Formula (V): wherein at least one instance of R21 is OR27, R27 is COR?? or Si(R28)3, and R??, R22, R23 R24, R25 and R26 are as defined herein; (ii) at least one phosphite or phosphonite; and (iii) a basic co-additive selected from alkali metal or alkaline metal salts of higher fatty acids. A polymeric hollow article is made by a process comprising: a) filling a mold with a polyolefin and a stabilizing amount of the stabilizer composition described herewith; b) rotating the mold around at least one axis while heating the mold in an oven, thereby fusing the composition and spreading it to the walls of the mold; c) cooling the mold; and d) opening the mold to remove the resulting polymeric hollow article.

Abstract: Polyolefin compositions of a polyolefin, a chroman-based compound according to Formula (V): and a basic co-additive selected from alkali metal or alkaline metal salts of higher fatty acids are disclosed. Amounts of the chroman-based compound and the basic co-additive are selected to enhance processing stability of the polyolefin composition when subjected to extrusion, even in the absence of antistatic agents and organic phosphites and phosphonites. Masterbatch compositions of a first polyolefin, the chroman-based compound and the basic co-additive can be blended with a second polyolefin, identical to, or compatible with, the first polyolefin to form a stabilized polyolefin composition. Molded articles produced by molding the polyolefin compositions are also disclosed. R21, R22, R23, R24, R25, R26, and R27 are also described.

Abstract: The cycle time of polymer compositions subjected to a rotomolding process is improved (i.e.

Abstract: Stabilizer compositions having a chroman-based compound according to Formula (V): and their use in processes for stabilizing organic materials subject to degradation and/or discoloration due to the effects from light, oxygen and heat, and in processes for producing articles from organic materials blended therewith, are provided herein.

Abstract: The present invention relates to reaction products H of at least one cyclic urea U, at least one multifunctional aldehyde A and at least one polyol P, process for preparing thereof and compositions comprising thereof.

Abstract: A method includes obtaining client information from a set of access points. The client information indicates client devices detected by each access point in the set of access points. In some implementations, the method includes grouping the set of access points into a plurality of access point groups based on the client information. The grouping allows each client device to associate with an access point from at least two different access point groups. The method includes, for a first access point group of the plurality of access point groups, migrating the client devices associated with access points in the first access point group to access points in a second access point group of the plurality of access point groups. In some implementations, the method includes configuring the access points in the first access point group while maintaining configuration of the access points in the second access point group.

Abstract: The invention relates to a coating composition comprising a reaction product UA of at least one multifunctional aldehyde A with at least one cyclic urea U, and a crosslinkable resin having at least one kind of functional groups selected from the group consisting of hydroxyl functional groups, acid functional groups, amide functional groups, amino functional groups, imino functional groups, mercaptan functional groups, phosphine functional groups, and carbamate functional groups, characterised in that the degree of etherification, measured as the ratio «(13 O—R)/«(U) of the amount of substance n(—O—R) of alkoxy groups as substituents of the aldehyde carbon atoms of the multifunctional aldehyde chemically bound in the reaction product UA to the amount of substance «(U) of cyclic urea U chemically bound in the reaction products, is less than 0.01 mol/mol, and to a process for the preparation of the reaction product UA.

Abstract: A method includes obtaining client information from a set of access points. The client information indicates client devices detected by each access point in the set of access points. In some implementations, the method includes grouping the set of access points into a plurality of access point groups based on the client information. The grouping allows each client device to associate with an access point from at least two different access point groups. The method includes, for a first access point group of the plurality of access point groups, migrating the client devices associated with access points in the first access point group to access points in a second access point group of the plurality of access point groups. In some implementations, the method includes configuring the access points in the first access point group while maintaining configuration of the access points in the second access point group.

Abstract: The present invention relates to reaction products H of at least one cyclic urea U, at least one multifunctional aldehyde A and at least one polyol P, process for preparing thereof and compositions comprising thereof.

Abstract: Present invention relates to a low dose pharmaceutical composition, preferably oral composition comprising therapeutically effective amount of [(2-hydroxy-4-oxo-6,7,8,9-tetrahydro-4H,5H-10-thia-1,4a-diaza-benzo[a]azulene-3-carbonyl)-amino]-acetic acid (compound A) in the range of 2.5 mg to 60 mg. Present invention also relates to a method of treating inflammatory bowel disease in a mammal by administrating said low dose pharmaceutical composition. Further, present invention relates to a use of the compound A for the preparation of low dose pharmaceutical composition for the treatment of inflammatory bowel disease in a mammal.

Abstract: The present invention relates to reaction products H of at least one cyclic urea U, at least one multifunctional aldehyde A and at least one polyol P, process for preparing thereof and compositions comprising thereof.

Abstract: The invention relates to a coating composition comprising a reaction product UA of at least one multifunctional aldehyde A with at least one cyclic urea U, and a crosslinkable resin having at least one kind of functional groups selected from the group consisting of hydroxyl functional groups, acid functional groups, amide functional groups, amino functional groups, imino functional groups, mercaptan functional groups, phosphine functional groups, and carbamate functional groups, characterised in that the degree of etherification, measured as the ratio «(13 O—R)/«(U) of the amount of substance n(—O—R) of alkoxy groups as substituents of the aldehyde carbon atoms of the multifunctional aldehyde chemically bound in the reaction product UA to the amount of substance «(U) of cyclic urea U chemically bound in the reaction products, is less than 0.01 mol/mol, and to a process for the preparation of the reaction product UA.

Abstract: The invention relates to a coating composition comprising a reaction product UA of at least one multifunctional aldehyde A with at least one cyclic urea U, and a crosslinkable resin having at least one kind of functional groups selected from the group consisting of hydroxyl functional groups, acid functional groups, amide functional groups, amino functional groups, imino functional groups, mercaptan functional groups, phosphine functional groups, and carbamate functional groups, characterized in that the degree of etherification, measured as the ratio <<(—O—R)/<<(U) of the amount of substance n(-O—R) of alkoxy groups as substituents of the aldehyde carbon atoms of the multifunctional aldehyde chemically bound in the reaction product UA to the amount of substance <<(U) of cyclic urea U chemically bound in the reaction products, is less than 0.01 mol/mol, and to a process for the preparation of the reaction product UA.

Abstract: The present invention relates to reaction products H of at least one cyclic urea U, at least one multifunctional aldehyde A and at least one polyol P, process for preparing thereof and compositions comprising thereof.

Abstract: A compound obtained by reaction of one or more amines of general formula NHR6R7 with a benzophenone derivative of the following general formula (IX) wherein M is a group comprising a number z of (meth)acrylate groups equal to at least one, L is a linker, G is linker comprising a number p? of unreacted hydroxyl groups, and R, R? and R?? are optional substituents as well as inks, coating compositions and adhesives comprising the same.

Abstract: A compound obtained by reaction of one or more amines of the general formula NHR6R7 with a compound of the following general formula (IX): wherein, PI is a photoinitiator derivative, G is linker comprising a number p? of unreacted hydroxyl groups, M is a group comprising a number z of (meth)acrylate groups equal to at least one, as well as inks, coating compositions and adhesives comprising the same.

Abstract: The invention relates to a reaction product UA of at least one cyclic urea U and at least one multifunctional aldehyde A which reaction product has as substituents on the carbonyl carbon atoms of the aldehyde A at least one kind of functional groups selected from the group consisting of hydroxyl groups —OH and alkoxy groups —OR characterised in that the groups —OR comprise at least two kinds of alkoxy groups —OR1 and —OR2, where R1 and R2 are both selected from the group consisting of linear, branched or cyclic alkyl groups having from one to twelve carbon atoms, where R1 and R2 may be the same or may be different from each other, to a process of making these, and to a method of use as crosslinker in coating compositions.

Abstract: Present invention relates to a low dose pharmaceutical composition, preferably oral composition comprising therapeutically effective amount of [(2-hydroxy-4-oxo-6,7,8,9-tetrahydro-4H,5H-10-thia-1,4a-diaza-benzo[a]azulene-3-carbonyl)-amino]-acetic acid (compound A) in the range of 2.5 mg to 60 mg. Present invention also relates to a method of treating inflammatory bowel disease in a mammal by administrating said low dose pharmaceutical composition. Further, present invention relates to a use of the compound A for the preparation of low dose pharmaceutical composition for the treatment of inflammatory bowel disease in a mammal.